Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.
Innovations in eye lens technology will continue to focus on improving patient’s functioning, with further progress being made in optimizing the cataract surgery process, said Raj Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson (J&J) Vision.
Transcript
Where do you see eye lens technology going in the next 5 to 10 years?
Certainly continuing to develop technology that continues to improve patient's functioning. We are hoping to continue to be able to provide options that patients can then choose, to minimize their need for glasses after cataract surgery.
We are also continuing to develop the instruments and the technology that's used in cataract surgery. We introduced at J&J Vision this year the VERITAS system, which is the phacoemulsification, or ultrasound system, that actually breaks apart the cataract during surgery.
So, as I was mentioning earlier, during cataract surgery, we make this microscopic incision, and then we use this phacoemulsification equipment, such as VERITAS, to break apart the hard lens. Just like in kidney stones, ultrasound is used to break apart the kidney stone. Then after we've removed all of the cataract, that's when we put the lens implant in place.
As I mentioned earlier, we also have developed and are continuing to develop advances in laser technology that also assist in that cataract surgery process in the operating room.
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More